Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-19 9:11 pm Purchase | 2024-03-15 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 66,199 19.900% | 41,979 (+173.32%) | Filing History |
| 2024-03-08 4:30 pm Purchase | 2024-03-06 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 24,220 9.900% | 254 (+1.06%) | Filing History |
| 2024-02-13 1:09 pm Sale | 2023-12-31 | 13G | BiomX Inc. PHGE | MMCAP International Inc. SPC | 8,042 3.220% | -3,657 (-31.26%) | Filing History |
| 2024-02-02 5:07 pm Sale | 2023-12-31 | 13G | BiomX Inc. PHGE | JOHNSON & JOHNSON JNJ | 11,123 4.600% | -105 (-0.94%) | Filing History |
| 2024-01-30 4:05 pm Purchase | 2024-01-30 | 13G | BiomX Inc. PHGE | Cystic Fibrosis Foundation | 23,960 9.900% | 9,481 (+65.48%) | Filing History |
| 2023-09-29 09:20 am Purchase | 2023-05-04 | 13G | BiomX Inc. PHGE | Rodney Hodges | 14,946 6.200% | 14,946 (New Position) | Filing History |
| 2023-06-23 4:50 pm Purchase | 2023-05-04 | 13G | BiomX Inc. PHGE | Burbank John Howard III | 24,201 9.990% | 24,201 (New Position) | Filing History |
| 2023-05-08 4:43 pm Purchase | 2023-05-04 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 23,966 9.900% | 5,353 (+28.76%) | Filing History |
| 2023-03-17 4:19 pm Purchase | 2023-02-27 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 18,613 10.500% | 6,558 (+54.40%) | Filing History |
| 2023-03-08 5:22 pm Purchase | 2023-02-27 | 13G | BiomX Inc. PHGE | Cystic Fibrosis Foundation | 14,479 8.100% | 14,479 (New Position) | Filing History |
| 2023-02-14 12:53 pm Purchase | 2022-12-31 | 13G | BiomX Inc. PHGE | MMCAP International Inc. SPC | 11,699 7.080% | 564 (+5.07%) | Filing History |
| 2023-02-13 3:57 pm Sale | 2022-12-31 | 13G | BiomX Inc. PHGE | Ugwumba Chidozie | 4,857 3.070% | -10,917 (-69.21%) | Filing History |
| 2022-11-14 5:10 pm Sale | 2022-11-04 | 13G | BiomX Inc. PHGE | Ugwumba Chidozie | 15,774 9.990% | -13,241 (-45.64%) | Filing History |
| 2022-08-04 7:59 pm Unchanged | 2022-03-25 | 13G | BiomX Inc. PHGE | Takeda Pharmaceutical Company Limited | 7,780 4.960% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:09 pm Sale | 2021-12-31 | 13G | BiomX Inc. PHGE | Walton Thomas Layton | 0 0.000% | -29,015 (Position Closed) | Filing History |
| 2022-02-14 3:49 pm Purchase | 2021-12-31 | 13G | BiomX Inc. PHGE | Ugwumba Chidozie | 29,015 19.280% | 29,015 (New Position) | Filing History |
| 2022-02-03 8:37 pm Purchase | 2021-12-31 | 13G | BiomX Inc. PHGE | MMCAP International Inc. SPC | 11,135 7.500% | 3,766 (+51.11%) | Filing History |
| 2021-10-18 06:03 am Sale | 2021-10-14 | 13G | BiomX Inc. PHGE | Takeda Pharmaceutical Company Limited | 7,780 5.200% | -5,224 (-40.17%) | Filing History |
| 2021-08-09 4:27 pm Purchase | 2021-07-28 | 13G | BiomX Inc. PHGE | Walton Thomas Layton | 29,015 17.800% | 29,015 (New Position) | Filing History |
| 2021-02-12 5:11 pm Purchase | 2020-12-31 | 13G | BiomX Inc. PHGE | MMCAP International Inc. SPC | 7,369 5.860% | 1,347 (+22.38%) | Filing History |